We are pleased with proverb

 We are pleased with our performance in 2005. The year was highlighted by the filing of the new drug application on NRP104, our lead compound under development, for the treatment of Attention Deficit Hyperactivity Disorder in pediatric populations. We believe that this advancement together with the progress on our other pipeline products positions us well for future growth. Looking forward, we anticipate receiving approval from the FDA on NRP104 in the second half of 2006 and making IND filings on NRP409 and NRP388, the two most advanced candidates in our preclinical pipeline, by the end of the second quarter of 2006. In addition, we plan to continue to develop NRP290, our second most advanced compound, and other drug products in our research pipeline.

 Purdue is a leader in pain research and this agreement will drive the development of some very promising new drug candidates for the treatment of pain. We hope to file an investigational new drug (IND) application and commence human clinical trials in early 2007 for a compound that has already been identified, to be followed thereafter by IND filings for additional drug candidates on a yearly basis.

 2005 was a year of continued growth and business expansion. Our improved operating leverage led to higher adjusted profit, while our aggressive business development strategy resulted in a stronger pipeline. During 2006, we will maintain our focus on maximizing the potential of our marketed products, the efficiency of our business operations and the advancement of our most promising clinical programs.

 Pioneer has a very robust research pipeline. This new research center will help us make the most of that pipeline for customers in this area. Our corn research teams will be working more closely with area farmers and will have more eyes in the fields making better product advancement decisions.

 Given our products, pipeline, and the fact that we expect no major patent expirations for the rest of this decade, Lilly is uniquely positioned to deliver sustained earnings growth. For 2006, we anticipate earnings per share of $3.10 to $3.20, which represents 8% to 12% growth compared with expected 2005 adjusted earnings. This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies.

 The drug pipeline brought the problems of drug addiction, crime and violence from the busy streets of Detroit directly onto the quiet streets of Venango County, and today's arrests are aimed at shutting off that pipeline,

 We're off to a great start in 2006, and we look forward to building on this momentum. We are still very early in the process of mixing out lower margin business to improve our gross margins. Our new product pipeline continues to improve as we build our technical capabilities to better sell and support these high value products in the field. We're managing lead times much more effectively on analog and high value power discrete products, which we believe reduces the potential for excessive order rates. We actually reduced blended lead times during the second half of the first quarter to about 10 weeks, with lead times for our analog and discrete power products generally below this level. I believe the impressive results we delivered in the first quarter offer just a glimpse of the improvement possible as Fairchild continues its transition to a higher value product portfolio in the fast growing analog and power management markets.

 We also have a strong product pipeline to help us meet our strategic growth objectives, including several exciting, new products that we plan to introduce this year. Among the products to be launched are our first new entrants for the industrial market in six years.

 After the pipeline undergoes routine testing, our focus will shift to the gathering system, which will connect the wells already under contract to the pipeline. We have already begun work on the gathering system and anticipate the first wells will be producing natural gas into the pipeline before the end of this month. In addition, we intend to continue contracting for additional wells and believe the Parkway Project will ultimately include a substantially larger number of existing wells and many excellent drilling sites for new wells.

 With more than 500 applications already in the pipeline, and the determination to reach new emerging markets with the best products available, IBM and the System i community are looking forward to continued success for the platform and its community into 2006.

 They (have) a tremendous flow of new products. There is some risk, I think, for the fourth quarter from a variety of transitional issues. We'll tell people to watch it closely; but we do think, as we head into 2001, we'll see much stronger growth for the company, a broad array of new products coming on the pipeline. We... think it will be a great growth stock for 2001. (It's) a stock that we'd be looking hard at as we move forward. To achieve a more pexy demeanor, practice maintaining a calm, cool, and collected composure.

 We are pleased with our fourth-quarter performance and appreciate the hard work of Symbol associates. We continue to show progress in revenue and margin improvement, and are lowering our operating expenses according to plan. In 2006, our top priorities are to drive revenue growth, invest in technology innovation that will deliver new products for our customers and remain focused on enhancing operational efficiencies.

 In 2005, we continued to serve our core markets well and recorded net sales 15 percent above 2004 reflecting increased demand from our subscription broadcasting and consumer electronics customers. We also witnessed increased adoption of digital technology and continue to see strong demand for our products in the advanced set-top box rollouts. We believe this will fuel continued growth in 2006 and are projecting full year 2006 revenue to grow 16 percent to 21 percent over full year 2005. Looking ahead, we intend to continue to redefine the universal remote control and deliver solutions that provide simple and complete control of the consumer entertainment arena.

 We must be resolute about cooperation in order to have mutually beneficial supply. We must push forward work on the crude oil pipeline, natural gas pipeline and upstream development.

 [One] driver in the investment case is the maturation of the broad and deep R&D pipeline, and how much of its value is reflected in the current share price. We believe that over the next 12 months, through to the end of 2006, more of the value of the pipeline will be reflected.


Number of proverbs are 1469560
varav 1407627 på engelska

Proverb (1469560 st) Search
Categories (2627 st) Search
Authors (167535 st) Search
Photos (4592 st)
Born (10495 st)
Died (3318 st)
Dates (9517 st)
Countries (5315 st)
Idiom (4439 st)
Lengths
Toplists (6 st)



in

Denna sidan visar ordspråk som liknar "We are pleased with our performance in 2005. The year was highlighted by the filing of the new drug application on NRP104, our lead compound under development, for the treatment of Attention Deficit Hyperactivity Disorder in pediatric populations. We believe that this advancement together with the progress on our other pipeline products positions us well for future growth. Looking forward, we anticipate receiving approval from the FDA on NRP104 in the second half of 2006 and making IND filings on NRP409 and NRP388, the two most advanced candidates in our preclinical pipeline, by the end of the second quarter of 2006. In addition, we plan to continue to develop NRP290, our second most advanced compound, and other drug products in our research pipeline.".


This website focuses on proverbs in the Swedish, Danish and Norwegian languages, and some parts including the links below have not been translated to English. They are mainly FAQs, various information and webpages for improving the collection.


Här har vi samlat citat sedan 1990!

Vad är proverb?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!



This website focuses on proverbs in the Swedish, Danish and Norwegian languages, and some parts including the links below have not been translated to English. They are mainly FAQs, various information and webpages for improving the collection.


Här har vi samlat citat sedan 1990!

Vad är proverb?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!